Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

GPhC appoints Louise Edwards as new Chief Strategy Officer

GPhC appoints Louise Edwards as new Chief Strategy Officer

Louise will succeed Mark Voce who is taking early retirement from the GPhC’s position in July 2024

The General Pharmaceutical Council (GPhC) has promoted Louise Edwards to the position of Chief Strategy Officer and Deputy Registrar.


Louise is currently the Director of Regulation and Digital Transformation at the Electoral Commission, responsible for the organisation’s regulatory work and digital, data, technology and facilities infrastructure.

This includes funding and spending at elections and referendums, registering political parties, enforcement work, and data and information management.

Louise will take over Mark Voce, the GPhC’s current Chief Strategy Officer and Deputy Registrar, who is retiring early in July 2024.

Louise said: "Pharmacy services are at the heart of health care for many people. Having effective regulation and standards in place can transform and give confidence in the quality of care that people receive.

“I am delighted to be appointed as the new Chief Strategy Officer and Deputy Registrar of the General Pharmaceutical Council, and having the opportunity to deliver its vital work to improve the health and well-being of people using pharmacy services.”

The Chief Strategy Officer is one of the four Chief Officers who share delegated authority from the Chief Executive & Registrar to lead the organisation and provide direction to senior management colleagues.

In her role as Chief Strategy Officer and Deputy Registrar, Louise will oversee the GPhC's strategy, pharmacy education and training, regulation reform, equality, diversity and inclusion, as well as its public affairs and external communication work across all teams. She will ensure these collectively follow a single strategic approach.

Duncan Rudkin, GPhC Chief Executive, said: “Our Chief Strategy Officer plays an absolutely critical role in delivering our vision and objectives. I am delighted that Louise will be taking on the role when she joins us in July, and I look forward to working closely with her.”

Duncan also paid tribute to Mark for “the enormous contribution he has made to pharmacy regulation” during his time in this role, and in his previous roles as Director of Education and Standards, and Head of Inspection.

“Mark’s achievements include leading our programme of work to transform the education and training of pharmacists and pharmacy technicians, both before and after registration.

“Mark has worked closely and effectively with stakeholders across Great Britain to introduce once-in-a-generation reforms which will mean that from 2026, all newly qualified pharmacists will be independent prescribers when they join the register,” he added.

According to Duncan, Louise will continue Mark's work to ensure that the regulation of the education and training of pharmacists and pharmacy technicians is strategically designed, implemented and developed to deliver on the vision agreed by the Council.

Louise will also oversee the development and evaluation of GPhC’s next five-year strategic plan, aimed at realising its vision for safe and effective pharmacy care at the heart of healthier communities.

Prior to joining the Electoral Commission, Louise worked for a range of regulators including the Charity Commission for England and Wales, The Independent Parliamentary Standards Authority, Ofgem and the Home Office.

More For You

NHS to invest millions to boost enhanced treatment for sickle cell patients

Approximately 17,000 people live in England with sickle cell disease

Pic credit: istock

NHS to invest millions to boost enhanced treatment for sickle cell patients

The Department of Health and Social Care has announced that it will invest £9 million towards the treatment of sickle cell patients.

Approximately 17,000 people live in England with sickle cell disease. Nearly 250 new cases of this inherited blood disorder is reported annually.

Keep ReadingShow less
NHS leads the world with new ‘trojan horse’ therapy for blood cancer patients

An estimated 6,000 cases of multiple myeloma is diagnosed in the UK each year.

Pic credit: istock

NHS leads the world with new ‘trojan horse’ therapy for blood cancer patients


NHS England has become the first in the world to introduce a ‘trojan horse’ therapy for the victims of blood cancer with the ground-breaking treatment slowing down the illness three-times more than existing treatments.

Keep ReadingShow less
Call to improve inclusivity in clinical research

Ethnic minority adults continue to be underrepresented in clinical trials.

iStock

Call to improve inclusivity in clinical research

A NEW report has called for the participation of a wide range of diverse communities in clinical research to make sure that the medicines meet the needs of the UK's increasingly diverse population.

The report ‘Achieving inclusivity in clinical research’, prepared by the Association of the British Pharmaceutical Industry (ABPI) and the Association of Medical Research Charities (AMRC), highlights the long-standing challenges in ensuring diversity in clinical trials.

Keep ReadingShow less
Pharmacy students Learning Support Fund

Pharmacy students will be included in the Travel and Dual Accommodation Expenses section of the NHS Learning Support Fund.

iStock

Pharmacy students to have access to Learning Support Fund

FOR the first time in England, pharmacy students will be eligible to reimburse travel and accommodation costs while attending placements.

The Department of Health and Social Care confirmed that pharmacy students would finally be included in the Travel and Dual Accommodation Expenses (TDAE) section of the NHS Learning Support Fund (LSF).

Keep ReadingShow less
NHS for robotic surgery

Patients undergoing robotic surgery are able to recover quicker and be discharged sooner.

Pic credit: iStock

NHS pushes for robotic surgery to reduce waiting time, improve outcomes

The NHS is planning to step up robotic surgery over the next decade to reduce waiting time, help in the speed of recovery of patients, and shorter hospital stay.

As per the NHS projections, the number is expected to zoom from 70,000 in 2023/24 to half a million by 2035.

Keep ReadingShow less